专利检索 ap:("CENTOCOR, INC.") AND inv:"SHANG, Xiaozhou" 第 1 页

1.

发明公开
CXCL13 ANTAGONISTS AND THEIR USE FOR THE TREATMENT OF INFLAMMATORY DISEASES 有权
标题翻译： CXCL-13拮抗剂和TNF-α拮抗剂联合使用治疗

公开(公告)号：EP2021016A2

公开(公告)日：2009-02-11

申请号：EP07761002.0

申请日：2007-04-20

申请人： CENTOCOR, INC.

发明人： BUGELSKI, Peter , DAS, Anuk , GRISWOLD, Donald E. , LIANG, Bailin , LI, Li , SARISKY, Robert A. , SHANG, Xiaozhou

IPC分类号： A61K38/28

CPC分类号： C07K16/241 , A61K2039/507 , C07K16/24 , C07K2317/76

摘要： Methods of treating disorders related to CXCL13 activity utilize CXCL13 antagonists and, optionally, TNFα antagonists, such as antibodies, including specified portions or variants, polypeptides, polynucleotides, siRNA, shRNA, ribozymes, and DNAzymes. Disorders related to CXCL13 activity include inflammatory disorders, such as pulmonary disorders, for example, asthma, emphysema, and COPD, and systemic lupus erythematosus.

2.

发明公开
COMPOSITIONS AND METHODS FOR IL13 BIOMARKERS 有权
标题翻译：组合物和生物标志物IL13方法

公开(公告)号：EP1943359A2

公开(公告)日：2008-07-16

申请号：EP06815683.5

申请日：2006-09-29

申请人： CENTOCOR, INC.

发明人： SYED, Farhat , HUANG, Chong, C. , LI, Katherine , LIU, Guihua , LI, Li , SHANG, Xiaozhou

IPC分类号： C12Q1/68 , G01N33/567 , A61K39/395

CPC分类号： C12Q1/6883 , C12Q2600/158 , G01N33/6863 , G01N2333/52 , G01N2800/122 , G01N2800/52

摘要： Compositions and methods are provided for measuring and determining biomarkers for IL-13.